Skip to content
Prism / Congress
Public preview100 Monkeys
All bills
HouseHR 2450Congress 119

Prescription Drug Transparency and Affordability Act

Retrieved from the GovBot source 9/24/2026, 1:39:17 PM (UTC). Viewing this record does not change stored data.

At a glance

Bill number
HR 2450
Status
Not provided
Latest recorded action
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Summary

Not provided in this source record.

Recorded activity

Newest date first. Actions with the same timestamp retain source order.

  1. Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  2. Introduced in House

Retrieval & source record
Search index built (UTC)
2026-09-07T10:23:11.520Z
Dataset
govbot-data/usa-legislation
Retrieved (UTC)
2026-09-24T13:39:17.889Z
Live source branch
main (mutable; checksum identifies the retrieved record)
Search index revision
b5b4a6d28d2dd595bb5724470458ffceaf19bcb7
Original record
View GovBot metadata JSON (opens in a new tab)
Record SHA-256
842d4ea7e1beb8458c2f4535a3592cda12b56b07d91d9c73aabf65e7f7c7218e